Ocular Therapeutix

Despite a more than 20 percent plunge in Ocular Therapeutix Inc (NASDAQ: OCUL)'s stock Wednesday morning, analysts at Cantor Fitzgerald continue to see tremendous upside in the stock. Cantor Fitzgerald's Elemer Piros maintains an Overweight rating on Ocular's stock but with a price...

Ocular Therapeutix Inc (NASDAQ: OCUL) shares sunk nearly 16 percent following a first-quarter earnings miss Friday. Despite the shares' current weakness, Cantor Fitzgerald reiterated its Overweight rating on the company with a $35 price target, well above Friday's $8. Analyst's Take On Earnings,...